Overview
Lobbying Costs
270,000€
Financial year: Apr 2023 - Mar 2024
Lobbyists (Full time equivalent)
1 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Kirkland Consulting
EU Transparency Register
371804028416-30 First registered on 21 Sep 2017
Goals / Remit
To provide scientific advice to companies, organisations and regulatory agencies on issues related to genotoxicity testing of chemical substances and interpretation of results.
Main EU files targeted
Clinical trial applications for pharmaceuticals, marketing applications for pharmaceuticals, REACH regulation for chemicals, EFSA assessment of food flavours and ingredients, cosmetics regulation, pesticides regulation, assessment of the safety of natural products (e.g. herbal remedies).
Website
-
People
Total lobbyists declared
1
Employment time Lobbyists 100% 1 Lobbyists (Full time equivalent)
1
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Self-employed individuals
-
Networking
Affiliation
Trustee of the European Environmental Mutagenesis and Genomics Society.
Emeritus Member of the US Environmental Mutagenesis and Genomics Society.
Health and Environmental Sciences Institute (HESI) Genetic Toxicology Technical Committee
Genetic Toxicology Association (USA)
UK Environmental Mutagen SocietyMember organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Apr 2023 - Mar 2024
Lobbying costs for closed financial year
270,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount titanium dioxide manufacturer's association REACH registration and safety of food colours 50,000€ - 99,999€ Tate & Lyle Safety of sweeteners 10,000€ - 24,999€ titanium dioxide industry consortium REACH Registration 10,000€ - 24,999€ remix therapeutics Pharmaceutical pre-clinical safety 0€ - 10,000€ xenometrix Method validation 0€ - 10,000€ vertex pharmaceuticals Pharmaceutical pre-clinical safety 0€ - 10,000€ danone sa Food safety 0€ - 10,000€ exscientia ai ltd. Pharmaceutical pre-clinical safety 0€ - 10,000€ teva branded pharmaceutical products Pharmaceutical pre-clinical safety 0€ - 10,000€ mironid limited Pharmaceutical pre-clinical safety 0€ - 10,000€ Philip Morris Pharmaceutical pre-clinical safety 0€ - 10,000€ reach monitor REACH Registration 0€ - 10,000€ neuron23, inc. Pharmaceutical pre-clinical safety 0€ - 10,000€ EPPA SA Safety of pesticides 0€ - 10,000€ dice alpha, inc. Pharmaceutical pre-clinical safety 0€ - 10,000€ zentiva k.s. Pharmaceutical pre-clinical safety 0€ - 10,000€ Elanco Safety of veterinary medicines 0€ - 10,000€ vifor ag Safety of pharmaceutical impurities 0€ - 10,000€ Leveret GmbH Safety of food flavourings 0€ - 10,000€ BMS Pharmaceutical pre-clinical safety 0€ - 10,000€ Boehringer Ingelheim Pharmaceutical pre-clinical safety 0€ - 10,000€ European Precious Metals Federation REACH Registration 0€ - 10,000€ onconova Pharmaceutical pre-clinical safety 0€ - 10,000€ Clients for current financial year
Clients list
Name Titanium Dioxide Manufacturers Association empress pharmaceuticals akkeri ndp inc. a.vogel ag titanium dioxide industry consortium Leveret GmbH mironid pharmaceuticals Japan Tobacco a. vogel phox consulting exscientia ai ltd. Elanco neuron23 Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Kirkland D, Aardema M J, Battersby R V, Beevers C, Burnett K, Burzlaff A, Czich A, Donner E M, Fowler P, Johnston H J, Krug H F, Pfuhler S, Stankowski Jr. L F (2022). A weight of evidence review of the genotoxicity of titanium dioxide (TiO2). Regul. Toxicol. Pharmacol. 136, 105263.
Douglas G R, Beevers C, Gollapudi B, Keig-Shevlin Z, Kirkland D, O’Brien J M, van Benthem J, Yauk C L, Young R R, Marchetti F (2022). Impact of Sampling Time on the Detection of Mutations in Rapidly Proliferating Tissues Using Transgenic Rodent Gene Mutation Models: A Review. Environ. Mol. Mutagen. 63, 376-388.
Beevers C, Uno Y, Meurer K, Hamada S, Hashimoto K, Kirkland D, LeBaron M J, Le Curieux F, Le Hegarat L, Martus H J, Masumura K, Ohyama W, Roberts D J, Vasquez M, Whitwell J, Witt K L (2023). In vivo genotoxicity testing strategies: Report from the 8th International Workshop on Genotoxicity Testing (IWGT). Environ. Mol. Mutagen. doi: 10.1002/em.22578. Epub ahead of print. PMID: 37942839.
Martus H-J, Zeller A, Kirkland D (2023). Reflections in Mutation Research. International Workshops on Genotoxicity Testing (IWGT): Origins, achievements and ambitions. Mutat. Res. 792, 108469.
Hendriks G, Adriaens E, Allemang A, Clements J, Cole G, Derr R, Engel M, Hamel A, Kidd D, Kellum S, Kiyota T, Myhre A, Naëssens V, Pfuhler S, Roy M, Settivari R, Schuler M, Zeller A, van Benthem J, Vanparys P, Kirkland D (2024). Interlaboratory validation of the ToxTracker assay: An in vitro reporter assay for mechanistic genotoxicity assessment. Environ. Mol. Mutagen. online version ahead of print https://doi.org/10.1002/em.22592Other activities
None declared
Meetings
Meetings
None declared